Realtime | Geld | Brief | Zeit |
---|---|---|---|
0,438 | 0,485 | 28.06. |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
02.06. | NOTICE OF extraordinary GENERAL MEETING in Senzime AB | 268 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / June 2, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - The shareholders in Senzime AB (publ) corp. reg. no 556565-5734 (the "Company") are hereby to an extraordinary general... ► Artikel lesen | |
SENZIME Aktie jetzt für 0€ handeln | |||||
26.05. | Senzime Applauds Announcement of Upcoming European Pediatric Guidelines of Neuromuscular Monitoring | 254 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / May 26, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Lisbon, Portugal - Senzime AB (publ.) welcomes today's pre-announcement of the first pediatric guidelines of quantitative... ► Artikel lesen | |
19.05. | BULLETIN from Annual General Meeting in Senzime AB | 262 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / May 19, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - The annual general meeting in Senzime AB (publ), corp. reg. no 556565-5734 (the "Company") was held on 19 May 2025 at... ► Artikel lesen | |
29.04. | Senzime Secures New TetraGraph Contract with State-Wide University Hospital System in Southern US | 235 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / April 29, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Uppsala, Sweden - Senzime AB today announced that it has secured another major US contract, this time with a top-ranked... ► Artikel lesen | |
24.04. | Senzime Publishes Annual and Sustainability Report for 2024 | 239 | ACCESS Newswire | UPPSALA, SWEDEN / ACCESS Newswire / April 24, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) announces today that the company's annual and sustainability report for 2024 is published and available at the website... ► Artikel lesen | |
23.04. | Senzime Secures New System-Wide Contract with Major Pacific Northwest US Healthcare System | 196 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / April 23, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) today announced that it has secured an additional system-wide contract with a US healthcare system. The contract includes... ► Artikel lesen | |
22.04. | Senzime: Interim Report January-March 2025: 94 Percent Growth | 202 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / April 22, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB's (publ) interim report for January - March 2025 is now available on the company's website www.senzime.comFinancial... ► Artikel lesen | |
14.04. | Invitation to Presentation of Senzime's First Quarter 2025 Report | 189 | ACCESS Newswire | UPPSALA, SWEDEN / ACCESS Newswire / April 14, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) invites investors, analysts, and media to a webcast presentation of the first quarter report for 2025 on April 22... ► Artikel lesen | |
14.04. | NOTICE OF ANNUAL GENERAL MEETING in Senzime AB | 250 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / April 14, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - The shareholders in Senzime AB (publ) corp. reg. no 556565-5734 (the "Company") are hereby convened to an annual general... ► Artikel lesen | |
03.04. | Senzime Comments on US Market Tariffs | 277 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / April 3, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Uppsala, Sweden - Senzime comments on the April 2 announcement on imposed new US import tariffs effective April 9, 2025."We... ► Artikel lesen | |
01.04. | New Number of Shares and Votes in Senzime AB | 175 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / April 1, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - The number of shares and votes in Senzime has increased during the month of March due to the directed issue of shares... ► Artikel lesen | |
14.03. | Senzime Secures Additional US Hospital System Contracts | 317 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / March 14, 2025 / Senzime AB (STO:SEZI)(OTCQX:SNZZF) today announced that it has secured new important US hospital system contracts including initial delivery of 60 next-generation... ► Artikel lesen | |
17.02. | Senzime: Interim report January - December 2024: Our Rapid Growth Journey Continued in 2024 with a 65% Growth Rate | 185 | ACCESS Newswire | UPPSALA, SWEDEN / ACCESS Newswire / February 17, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime AB's (publ) interim report for January - December 2024 is now available on the company's website www.senzime.com.Financial... ► Artikel lesen | |
13.02. | Invitation to Presentation of Senzime's Fourth Quarter 2024 Report | 230 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / February 13, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime invites investors, analysts, and media to a webcast presentation of the fourth quarter report for 2024 on... ► Artikel lesen | |
13.01. | Senzime Reaches Second Milestone of Masimo Collaboration with Launch of Integration to Iris Gateway | 484 | ACCESS Newswire | UPPSALA, SWEDEN / ACCESSWIRE / January 13, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime AB (publ.), a leader in precision-based patient monitoring, today announced that the company has reached a second... ► Artikel lesen | |
07.01. | Senzime Secures Multiple New Hospital Contracts for its Next-Generation TetraGraph System | 553 | ACCESS Newswire | UPPSALA, SE / ACCESSWIRE / January 7, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime,an industry leader in precision-based patient monitoring solutions, today announced multiple hospital contract wins... ► Artikel lesen | |
03.01. | New Number of Shares and Votes in Senzime AB | 324 | ACCESS Newswire | UPPSALA, SWEDEN / ACCESSWIRE / January 3, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) The number of shares and votes in Senzime AB (publ) ("Senzime") has increased during December due to the directed share... ► Artikel lesen | |
06.11.24 | Senzime: Interim Report January - September 2024: Strong Sales Growth Driven by Accelerated Sensor Sales | 233 | ACCESS Newswire | UPPSALA, SE / ACCESSWIRE / November 06, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Press release: Uppsala, November 6th, 2024. Senzime AB's (publ) interim report for January - September 2024 is now available... ► Artikel lesen | |
31.10.24 | New Number of Shares and Votes in Senzime AB | 278 | ACCESS Newswire | UPPSALA, SWEDEN / ACCESSWIRE / October 31, 2024 / The number of shares and votes in Senzime AB (publ) (STO:SEZI)(OTCQX:SNZZF) ("Senzime") has increased during October due to the directed share issue... ► Artikel lesen | |
30.10.24 | Invitation to Presentation of Senzime's Third Quarter 2024 Report | 339 | ACCESS Newswire | UPPSALA, SWEDEN / ACCESSWIRE / October 30, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) invites investors, analysts, and media to a webcast presentation of the third quarter report for 2024 on November 6... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SIEMENS HEALTHINEERS | 46,900 | +0,13 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
FRESENIUS | 42,590 | +0,95 % | Aktienmarkt: Fresenius SE & Co. KGaA-Aktie kann sich nicht behaupten (42,16 €) | Der Anteilsschein von Fresenius SE & Co. KGaA notiert am Mittwoch leichter. Die Aktie kostete zuletzt 42,16 Euro. Für Inhaber von Fresenius+Co KgaA ist der heutige Handelstag bisher nicht sonderlich... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 48,300 | +0,52 % | BERENBERG stuft FMC FRESENIUS MEDICAL CARE AG auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius Medical Care (FMC) von 55 auf 60 Euro angehoben und die Einstufung auf "Buy" belassen. Analystin Victoria Lambert... ► Artikel lesen | |
GERRESHEIMER | 48,080 | +1,26 % | Gerresheimer-Aktie heute gut behauptet: Aktienwert steigt (47,28 €) | Am deutschen Aktienmarkt notiert der Anteilsschein von Gerresheimer gegenwärtig etwas fester. Die Aktie kostete zuletzt 47,28 Euro. Die Aktie von Gerresheimer verzeichnet derzeit einen Preisanstieg... ► Artikel lesen | |
CARL ZEISS MEDITEC | 57,00 | +1,06 % | Carl Zeiss Meditec AG: Chirurgische Präzision, strategische Genauigkeit; mwb research stuft auf KAUFEN | Carl Zeiss Meditec (CZM) bleibt ein weltweit führender Anbieter in der Augenheilkunde und Mikrochirurgie, gestützt durch strukturelle Wachstumstreiber wie demografischen Wandel und die Zunahme von Sehstörungen.... ► Artikel lesen | |
HIMS & HERS HEALTH | 42,410 | +0,43 % | Kein Wegovy mehr: Novo Nordisk bricht Partnerschaft: Hims & Hers-Aktie fällt ins Bodenlose! | © Foto: Christian Schultz/dpaNovo Nordisk bricht mit Hims & Hers: Beide Aktien fallen drastisch, wobei der Telemedizinanbieter aus den USA den Kürzeren zieht.Tiefschlag für die Anteilsscheine von Hims... ► Artikel lesen | |
GENEDX | 91,13 | +1,72 % | Why GeneDX Stock Surged Higher This Week | ||
UNITEDHEALTH | 263,95 | -0,02 % | Dividendenbekanntmachungen (24.06.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) COMPAGNIE DE L ODET SA FR0000062234 - 4,4 EUR DOM DEVELOPMENT SA PLDMDVL00012 7 PLN 1,6374 EUR ELBIT SYSTEMS LTD IL0010811243 0... ► Artikel lesen | |
PROGYNY | 21,910 | +2,10 % | Here's Why Progyny (PGNY) Rebounded in Q1 | ||
BRIGHTSPRING HEALTH SERVICES | 23,540 | +2,08 % | TD Cowen Begins Coverage of BrightSpring Health Services (BTSG) Stock, Gives Buy | ||
ECKERT & ZIEGLER | 67,85 | +2,03 % | Leichte Zugewinne bei der Eckert&Ziegler-Aktie (65,60 €) | Die Eckert&Ziegler-Aktie notiert heute etwas fester. Das Wertpapier kostete zuletzt 65,60 Euro. Eine Verteuerung in Höhe von 1,75 Euro erfreut derzeit die Aktionäre von Eckert&Ziegler. Zur Stunde kostet... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 56,91 | -2,93 % | PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2024 Results | SAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
AUTONOMIX MEDICAL | 1,960 | +58,06 % | Autonomix Medical, Inc. Granted New U.S. Patent for Innovative Catheter-Based Platform Technology | Patent supports the Company's broader mission to advance minimally invasive, nerve-focused treatments across high-need indications Strengthens strategic position in a multi-billion-dollar market opportunity... ► Artikel lesen | |
LIFEMD | 13,760 | +1,62 % | LifeMD-Aktie steigt nach Fortsetzung der Wegovy-Partnerschaft mit Novo Nordisk | ||
ALIGNMENT HEALTHCARE | 13,850 | +0,65 % | Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition | Delivers Q1 revenue of $926.9 million, up 47.5% year over year, and grows Medicare Advantage (MA) membership by 31.7% to approximately 217,500 membersExceeds high-end of Q1 guidance on membership... ► Artikel lesen |